Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity

By van den Bent M.J.   van Putten W.L.J.   Hilkens P.H.E.   de Wit R.   van der Burg M.E.L.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 387-391

Elsevier

Access to resources Recommend Favorite

Neurological Monitoring of Neurotoxicity Induced by Paclitaxel/Cisplatin Chemotherapy

By Berger T.   Malayeri R.   Doppelbauer A.   Krajnik G.   Huber H.   Auff E.   Pirker R.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1393-1399

Elsevier

Access to resources Recommend Favorite

Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats

By Orhan Bulent   Yalcin Suayib   Nurlu Gulay   Zeybek Dilara   Muftuoglu Sevda  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 197-203

Humana Press, Inc

Access to resources Recommend Favorite

Pre-exposure of human squamous carcinoma cells to low-doses of gamma-rays leads to an increased resistance to subsequent low-dose cisplatin treatment

By Caney C.   Bulmer J. T.   Singh G.   Lukka H.   Rainbow A. J.  

International Journal of Radiation Biology, Vol. 75, Iss. 8, 1999-08 ,pp. : 963-972

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

By Han Ji-Youn   Lee Dae   Lee Sung   Park Chun   Kim Hae   Kim Eun-A   Yoon Sung   Lee Hong   Lee Jin  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 281-290

Humana Press, Inc

Access to resources Recommend Favorite